October 24, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
| Attention: |
Jason Drory and Laura Crotty |
|
Re:
|
Catalyst Biosciences, Inc.
Registration Statement on Form S-3 (File No. 333-273395)
|
Ladies and Gentlemen:
Catalyst Biosciences, Inc. hereby respectfully requests that, pursuant to Rule 461 promulgated under the Securities
Act of 1933, as amended, the effectiveness of the above-referenced Registration Statement on Form S-3 be accelerated so that it will become effective on October 27, 2023, at 9:00 a.m., Eastern Time, or as soon as practicable thereafter, unless we
or our outside counsel, Orrick, Herrington & Sutcliffe LLP, request by telephone that such Registration Statement be declared effective at some other time.
We request that we be notified of such effectiveness by a telephone call to Stephen Thau of Orrick, Herrington &
Sutcliffe LLP at (212) 506-5076.
|
|
|
Sincerely, |
|
|
|
|
|
|
|
|
|
CATALYST BIOSCIENCES, INC.
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Nassim Usman
|
|
|
|
|
Nassim Usman, Ph.D.
|
|
|
|
|
President and Chief Executive Officer
|
|
cc:
|
Stephen Thau, Orrick, Herrington & Sutcliffe LLP
|